Yangli Ye

669 total citations
20 papers, 512 citations indexed

About

Yangli Ye is a scholar working on Renewable Energy, Sustainability and the Environment, Materials Chemistry and Molecular Biology. According to data from OpenAlex, Yangli Ye has authored 20 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Renewable Energy, Sustainability and the Environment, 6 papers in Materials Chemistry and 5 papers in Molecular Biology. Recurrent topics in Yangli Ye's work include Nanocluster Synthesis and Applications (3 papers), Carbon and Quantum Dots Applications (3 papers) and Diabetes Treatment and Management (3 papers). Yangli Ye is often cited by papers focused on Nanocluster Synthesis and Applications (3 papers), Carbon and Quantum Dots Applications (3 papers) and Diabetes Treatment and Management (3 papers). Yangli Ye collaborates with scholars based in China and United States. Yangli Ye's co-authors include Chongxin Shan, Cheng‐Long Shen, Qing Lou, Lin Dong, Jinhao Zang, Chenhe Zhao, Xinhua Qu, Mingxiang Yu, Jianyong Wei and Zhejing Bao and has published in prestigious journals such as Bioresource Technology, International Journal of Hydrogen Energy and Energy.

In The Last Decade

Yangli Ye

20 papers receiving 503 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yangli Ye China 11 228 129 109 106 73 20 512
Guojuan Chen China 15 264 1.2× 99 0.8× 277 2.5× 152 1.4× 83 1.1× 41 666
Bruce O’Rourke United States 8 58 0.3× 83 0.6× 99 0.9× 63 0.6× 18 0.2× 9 423
Fengrui Wang China 10 138 0.6× 109 0.8× 20 0.2× 57 0.5× 91 1.2× 29 328
Jingyi Cui China 16 127 0.6× 32 0.2× 198 1.8× 73 0.7× 10 0.1× 31 696
Zixing Shao China 9 115 0.5× 70 0.5× 36 0.3× 19 0.2× 9 0.1× 11 360
Huan Yao China 16 234 1.0× 103 0.8× 279 2.6× 35 0.3× 7 0.1× 46 864
Lijun Hu China 12 130 0.6× 146 1.1× 141 1.3× 174 1.6× 79 1.1× 48 525
Xinxin Liu China 9 181 0.8× 219 1.7× 44 0.4× 95 0.9× 6 0.1× 17 350
Xuelian Zhou China 11 25 0.1× 46 0.4× 98 0.9× 21 0.2× 50 0.7× 48 401
Yongchuan Wang China 9 158 0.7× 130 1.0× 69 0.6× 61 0.6× 9 0.1× 27 431

Countries citing papers authored by Yangli Ye

Since Specialization
Citations

This map shows the geographic impact of Yangli Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangli Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangli Ye more than expected).

Fields of papers citing papers by Yangli Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yangli Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangli Ye. The network helps show where Yangli Ye may publish in the future.

Co-authorship network of co-authors of Yangli Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Yangli Ye. A scholar is included among the top collaborators of Yangli Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yangli Ye. Yangli Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ye, Yangli, et al.. (2024). Exploring SGLT-2 inhibitors and sarcopenia in FAERS: a post-marketing surveillance study. Expert Opinion on Drug Safety. 25(1). 95–102. 3 indexed citations
2.
Ye, Yangli, et al.. (2024). Advances in the Understanding of the Pathogenesis of Triple‐Negative Breast Cancer. Cancer Medicine. 13(22). e70410–e70410. 2 indexed citations
3.
Ma, Yuanji, Wei Dong Gao, Xiaoxue Zhang, et al.. (2024). Potential diagnostic value of circulating miRNAs in HFrEF and bioinformatics analysis. Heliyon. 10(19). e37929–e37929. 3 indexed citations
4.
Ye, Yangli, et al.. (2024). GLP-2 ameliorates D-galactose induced muscle aging by IGF-1/Pi3k/Akt/FoxO3a signaling pathway in C2C12 cells and mice. Archives of Gerontology and Geriatrics. 124. 105462–105462. 8 indexed citations
6.
Ye, Yangli, Jian Gao, Jing Liang, et al.. (2021). Association between preoperative lipid profiles and new‐onset diabetes after transplantation in Chinese kidney transplant recipients: A retrospective cohort study. Journal of Clinical Laboratory Analysis. 35(8). e23867–e23867. 6 indexed citations
8.
Liu, Zhiyu, Chunfeng Wang, Zhili Zhu, et al.. (2021). Wafer-scale growth of two-dimensional graphitic carbon nitride films. Matter. 4(5). 1625–1638. 71 indexed citations
9.
Shen, Cheng‐Long, Jinhao Zang, Qing Lou, et al.. (2021). Surface chemical engineering towards efficient and bright chemiluminescent carbon nanodots. Applied Surface Science. 559. 149947–149947. 10 indexed citations
10.
Ye, Yangli, Qing Lou, Cheng‐Long Shen, et al.. (2020). Reprintable paper realized employing ZnO-based photocatalytic color conversion of dyes. Journal of Physics D Applied Physics. 53(46). 465107–465107. 5 indexed citations
11.
Liu, Guangwang, Yao Zhang, Guiping Xu, et al.. (2020). Linear and Non-linear Correlations Between Serum Phosphate Level and Bone Mineral Density in Type 2 Diabetes. Frontiers in Endocrinology. 11. 497–497. 3 indexed citations
12.
Zhao, Chenhe, et al.. (2020). Prospect of Sodium–Glucose Co-transporter 2 Inhibitors Combined With Insulin for the Treatment of Type 2 Diabetes. Frontiers in Endocrinology. 11. 190–190. 32 indexed citations
13.
Wei, Jianyong, Qing Lou, Jinhao Zang, et al.. (2020). Scalable Synthesis of Green Fluorescent Carbon Dot Powders with Unprecedented Efficiency. Advanced Optical Materials. 8(7). 99 indexed citations
14.
Ye, Yangli, et al.. (2019). Effect of Sodium-Glucose Co-transporter 2 Inhibitors on Bone Metabolism and Fracture Risk. Frontiers in Pharmacology. 9. 1517–1517. 52 indexed citations
15.
Zhao, Chenhe, Guangwang Liu, Yao Zhang, et al.. (2019). Association between serum levels of bone turnover markers and bone mineral density in men and women with type 2 diabetes mellitus. Journal of Clinical Laboratory Analysis. 34(4). e23112–e23112. 14 indexed citations
16.
Su, Lixia, Zhiyu Liu, Yangli Ye, et al.. (2019). Heterostructured boron doped nanodiamonds@g-C3N4 nanocomposites with enhanced photocatalytic capability under visible light irradiation. International Journal of Hydrogen Energy. 44(36). 19805–19815. 37 indexed citations
17.
Bao, Zhejing, Yangli Ye, & Lei Wu. (2019). Multi-timescale coordinated schedule of interdependent electricity-natural gas systems considering electricity grid steady-state and gas network dynamics. International Journal of Electrical Power & Energy Systems. 118. 105763–105763. 33 indexed citations
18.
Liu, Guangwang, Yao Zhang, Guiping Xu, et al.. (2018). Association Between Bone Mineral Density, Bone Turnover Markers, and Serum Cholesterol Levels in Type 2 Diabetes. Frontiers in Endocrinology. 9. 646–646. 16 indexed citations
20.
Shen, Cheng‐Long, Guangsong Zheng, Mengyuan Wu, et al.. (2018). Chemiluminescent carbon nanodots as sensors for hydrogen peroxide and glucose. Nanophotonics. 9(11). 3597–3604. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026